Literature DB >> 10513728

Are drugs within a class interchangeable?

C D Furberg1, D M Herrington, B M Psaty.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10513728     DOI： 10.1016/S0140-6736(99)03190-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  21 in total

1.  Statins: underused by those who would benefit.

Authors:  S B Hulley; D Grady; W S Browner
Journal:  BMJ       Date:  2000-10-21

2.  Evidence-based medicine: worship of form and treatment of high blood pressure.

Authors:  B M Psaty; C Rhoads; C D Furberg
Journal:  J Gen Intern Med       Date:  2000-10       Impact factor: 5.128

3.  Did the major clinical trials of statins affect prescribing behaviour?

Authors:  M M Mamdani; J V Tu
Journal:  CMAJ       Date:  2001-06-12       Impact factor: 8.262

4.  Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect.

Authors:  Zheng Zhou; Elham Rahme; Michal Abrahamowicz; Jack V Tu; Mark J Eisenberg; Karin Humphries; Peter C Austin; Louise Pilote
Journal:  CMAJ       Date:  2005-04-26       Impact factor: 8.262

5.  Rule-based standardised switching of drugs at the interface between primary and tertiary care.

Authors:  Stefanie U Walk; Thilo Bertsche; Jens Kaltschmidt; Markus G Pruszydlo; Torsten Hoppe-Tichy; Ingeborg Walter-Sack I; Walter E Haefeli
Journal:  Eur J Clin Pharmacol       Date:  2007-11-25       Impact factor: 2.953

6.  Dihydropyridine calcium channel blockers and cardiovascular outcomes in elderly patients: a population-based study.

Authors:  Claudia Bucci; Muhammad M Mamdani; David N Juurlink; Jack V Tu
Journal:  Can J Cardiol       Date:  2008-08       Impact factor: 5.223

7.  Society already achieves economic benefits from generic substitution but fails to do the same for therapeutic substitution.

Authors:  Pearl D Gumbs; W M Monique Verschuren; Patrick C Souverein; Aukje K Mantel-Teeuwisse; G Ardine de Wit; Anthonius de Boer; Olaf H Klungel
Journal:  Br J Clin Pharmacol       Date:  2007-09-13       Impact factor: 4.335

Review 8.  Pharmacological management of chronic heart failure in adults: a review of the literature.

Authors:  Richard Auty
Journal:  Malawi Med J       Date:  2004-03       Impact factor: 0.875

Review 9.  Do ACE inhibitors all provide the same outcomes benefits in high-risk cardiovascular patients?

Authors:  Anu Lala; Mary Ann McLaughlin
Journal:  Curr Hypertens Rep       Date:  2008-08       Impact factor: 5.369

Review 10.  Ramipril: a review of its use in the prevention of cardiovascular outcomes.

Authors:  Gregory T Warner; Caroline M Perry
Journal:  Drugs       Date:  2002       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.